RXO, Inc.
RXO · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -7.10 | -0.56 | 0.07 |
| FCF Yield | -1.79% | 0.92% | 12.64% | 4.75% |
| EV / EBITDA | -20.37 | 31.76 | 12.06 | 9.21 |
| Quality | ||||
| ROIC | -2.11% | 3.25% | 7.60% | 11.65% |
| Gross Margin | 15.30% | 16.76% | 24.44% | 21.50% |
| Cash Conversion Ratio | 0.04 | 22.25 | 3.37 | 1.03 |
| Growth | ||||
| Revenue 3-Year CAGR | -1.74% | -5.74% | 12.63% | 14.29% |
| Free Cash Flow Growth | -328.00% | -90.12% | 118.10% | 627.27% |
| Safety | ||||
| Net Debt / EBITDA | -3.36 | 5.37 | 2.48 | 0.38 |
| Interest Coverage | -1.87 | 1.22 | 30.75 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 44.64 | 22.83 | 18.04 | 27.06 |